Revvity Other Non-Current Liabilities 2010-2024 | RVTY
Revvity other non-current liabilities from 2010 to 2024. Other non-current liabilities can be defined as field containing the sum of all non-current liabilities that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Revvity other non-current liabilities for the quarter ending December 31, 2024 were $0.846B, a 14.81% decline year-over-year.
- Revvity other non-current liabilities for 2023 were $0.931B, a 16.07% decline from 2022.
- Revvity other non-current liabilities for 2022 were $1.109B, a 22.26% decline from 2021.
- Revvity other non-current liabilities for 2021 were $1.427B, a 84.21% increase from 2020.
| Revvity Annual Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $931 |
| 2022 | $1,109 |
| 2021 | $1,427 |
| 2020 | $775 |
| 2019 | $751 |
| 2018 | $742 |
| 2017 | $849 |
| 2016 | $460 |
| 2015 | $465 |
| 2014 | $443 |
| 2013 | $417 |
| 2012 | $442 |
| 2011 | $470 |
| 2010 | $344 |
| 2009 | $364 |
| Revvity Quarterly Other Non-Current Liabilities (Millions of US $) |
|
|---|---|
| 2024-09-30 | $846 |
| 2024-06-30 | $879 |
| 2024-03-31 | $920 |
| 2023-12-31 | $931 |
| 2023-09-30 | $993 |
| 2023-06-30 | $954 |
| 2023-03-31 | $1,010 |
| 2022-12-31 | $1,109 |
| 2022-09-30 | $1,232 |
| 2022-06-30 | $1,311 |
| 2022-03-31 | $1,355 |
| 2021-12-31 | $1,427 |
| 2021-09-30 | $1,512 |
| 2021-06-30 | $839 |
| 2021-03-31 | $828 |
| 2020-12-31 | $775 |
| 2020-09-30 | $721 |
| 2020-06-30 | $703 |
| 2020-03-31 | $704 |
| 2019-12-31 | $751 |
| 2019-09-30 | $690 |
| 2019-06-30 | $717 |
| 2019-03-31 | $689 |
| 2018-12-31 | $742 |
| 2018-09-30 | $721 |
| 2018-06-30 | $744 |
| 2018-03-31 | $785 |
| 2017-12-31 | $849 |
| 2017-09-30 | $496 |
| 2017-06-30 | $488 |
| 2017-03-31 | $463 |
| 2016-12-31 | $460 |
| 2016-09-30 | $489 |
| 2016-06-30 | $488 |
| 2016-03-31 | $487 |
| 2015-12-31 | $465 |
| 2015-09-30 | $396 |
| 2015-06-30 | $401 |
| 2015-03-31 | $403 |
| 2014-12-31 | $443 |
| 2014-09-30 | $398 |
| 2014-06-30 | $408 |
| 2014-03-31 | $409 |
| 2013-12-31 | $417 |
| 2013-09-30 | $409 |
| 2013-06-30 | $386 |
| 2013-03-31 | $381 |
| 2012-12-31 | $442 |
| 2012-09-30 | $434 |
| 2012-06-30 | $417 |
| 2012-03-31 | $445 |
| 2011-12-31 | $470 |
| 2011-09-30 | $431 |
| 2011-06-30 | $409 |
| 2011-03-31 | $373 |
| 2010-12-31 | $344 |
| 2010-09-30 | $344 |
| 2010-06-30 | $368 |
| 2010-03-31 | $369 |
| 2009-12-31 | $364 |
| 2009-09-30 | $364 |
| 2009-06-30 | $347 |
| 2009-03-31 | $330 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.997B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.052B | 27.37 |
| Elevance Health (ELV) | United States | $90.846B | 11.88 |
| CVS Health (CVS) | United States | $83.717B | 12.25 |
| Cencora (COR) | United States | $47.591B | 17.27 |
| DiDi Global (DIDIY) | China | $23.087B | 0.00 |
| Natera (NTRA) | United States | $22.788B | 0.00 |
| ICON (ICLR) | Ireland | $15.783B | 14.04 |
| Doximity (DOCS) | United States | $14.316B | 74.45 |
| BioMerieux (BMXMF) | France | $14.074B | 0.00 |
| Viatris (VTRS) | United States | $13.046B | 4.02 |
| Solventum (SOLV) | United States | $12.780B | 0.00 |
| Avantor (AVTR) | United States | $12.038B | 17.68 |
| CochLear (CHEOY) | Australia | $11.471B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.479B | 27.23 |
| HealthEquity (HQY) | United States | $9.860B | 49.47 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $9.450B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.815B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.437B | 15.99 |
| Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
| Bausch + Lomb (BLCO) | Canada | $5.745B | 26.29 |
| Organon (OGN) | United States | $3.938B | 4.01 |
| Sotera Health (SHC) | United States | $3.861B | 20.65 |
| BrightSpring Health Services (BTSG) | United States | $3.639B | 77.41 |
| Surgery Partners (SGRY) | United States | $3.282B | 37.42 |
| GeneDx Holdings (WGS) | United States | $3.058B | 371.03 |
| Concentras Parent (CON) | United States | $2.973B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.699B | 0.00 |
| Teladoc Health (TDOC) | United States | $2.371B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.078B | 0.00 |
| Progyny (PGNY) | United States | $2.017B | 40.85 |
| PACS (PACS) | United States | $2.006B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.955B | 51.30 |
| Premier (PINC) | United States | $1.711B | 10.96 |
| Agilon Health (AGL) | United States | $1.471B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| CareDx (CDNA) | United States | $1.325B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.212B | 11.86 |
| Establishment Labs Holdings (ESTA) | $1.010B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.908B | 6.14 |
| Embecta (EMBC) | United States | $0.899B | 6.16 |
| Auna S.A (AUNA) | Luxembourg | $0.633B | 0.00 |
| DocGo (DCGO) | United States | $0.562B | 21.19 |
| Sonida Senior Living (SNDA) | United States | $0.499B | 0.00 |
| SBC Medicals (SBC) | United States | $0.483B | 0.00 |
| MultiPlan (MPLN) | United States | $0.476B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.453B | 0.00 |
| Enhabit (EHAB) | United States | $0.440B | 38.09 |
| Nutex Health (NUTX) | United States | $0.352B | 0.00 |
| LifeMD (LFMD) | United States | $0.345B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.308B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.294B | 7.71 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.183B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.144B | 0.00 |
| Biodesix (BDSX) | United States | $0.138B | 0.00 |
| So-Young (SY) | China | $0.118B | 19.98 |
| IceCure Medical (ICCM) | Israel | $0.086B | 0.00 |
| ModivCare (MODV) | United States | $0.082B | 4.46 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| Oncology Institute (TOI) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.60 |
| Singular Genomics Systems (OMIC) | United States | $0.051B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.022B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.020B | 0.00 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |